Société de Therapeutique Marocaine S.A.

CBSE-SOT
Casablanca Stock Exchange
Pharmaceutical Preparations
Global Rank
#8805
Country Rank
#21
Market Cap
1.16 B
Price
166.48
Change (%)
3.23%
Volume
99

Société de Therapeutique Marocaine S.A.'s latest marketcap:

1.16 B

As of 07/05/2025, Société de Therapeutique Marocaine S.A.'s market capitalization has reached $1.16 B. According to our data, Société de Therapeutique Marocaine S.A. is the 8805th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.16 B
Revenue (ttm) 312.54 M
Net Income (ttm) 34.99 M
Shares Out 7.2 M
EPS (ttm) 4.86
Forward PE 33.70
Ex-Dividend Date 06/20/2025
Earnings Date 07/31/2025
Market Cap Chart
Data Updated: 07/05/2025

Société de Therapeutique Marocaine S.A.'s yearly market capitalization.

Société de Therapeutique Marocaine S.A. has seen its market value drop from 2.43 B MAD to 1.16 B MAD since 2014, representing a total decrease of 52.12% and an annual compound decline rate (CAGR) of 6.76%.
Date Market Cap(MAD) Change (%) Global Rank
07/05/2025 1.16 B 67.57% 8805
12/31/2024 6.66 B -2.73% 11216
12/29/2023 6.85 B -27.95% 10854
12/30/2022 9.5 B -10.81% 8765
12/31/2021 10.66 B 196% 8622
12/29/2020 3.6 B 23.38% 12831
12/27/2019 2.92 B -1.1% 12683
12/28/2018 2.95 B 9.27% 11668
12/22/2017 2.7 B 27.01% 13070
12/20/2016 2.13 B -3.2% 12628

Company Profile

About Société de Therapeutique Marocaine S.A.

Société de Therapeutique Marocaine S.A. is a leading pharmaceutical company specializing in the manufacturing and sale of medicines in Morocco. Established in 1976 and headquartered in Bouskoura, the company serves both domestic and international markets.

Key Offerings

  • Diverse Therapeutic Areas: Products span allergology, oncology, cardiology, dental care, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatrics, pulmonology, reanimation, rheumatology, CNS, and urology.
  • Generic & Specialty Medicines: Includes antibiotics and other generic drugs.
  • Multiple Product Forms: Tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams, injectable solutions, and self-injectable syringes.

Additional Services

  • Imports licensed medicines, dental products, and biotechnology solutions.
  • Manufactures medicines under private labels for third-party brands.

Global Reach

The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf, reinforcing its presence in international markets.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.